An Exploratory Approach for Validation and Standardization of Test Methods and Evaluators to Conduct In-Vivo Clinical Safety and Efficacy Testing of Hair Care Range of Products
Sponsor study identifier
observational
40
1 country
1
Study Start
April 12, 2023
Actual (reported)Primary Completion
May 1, 2023
Actual (reported)Study Completion
May 1, 2023
Actual (reported)An exploratory approach for validation and standardization of test methods and evaluators to conduct In-Vivo clinical safety and efficacy testing of hair care range of products. A total of 40 subjects will be enrolled.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 1, 2023
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 28, 2023
Actual (reported)March 10, 2023
Actual (reported)April 12, 2023
Actual (reported)May 1, 2023
Actual (reported)May 1, 2023
Actual (reported)Evaluate the standardize the methods, procedural steps
Validate the hair growth rate measurement
Day 01 to Day 04
Evaluate the standardize the methods, procedural steps
60-s combing test
Day 01 to Day 04
Evaluate the standardize the methods, procedural steps
Hair Pull test
Day 01 to Day 04
Evaluate the standardize the methods, procedural steps
Hair Pluck test
Day 01 to Day 04
Evaluate the standardize the methods, procedural steps
Subjective scoring of Hair quality appearance and scalp condition
Day 01 to Day 04
No intervention will be given to the subject
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Referring to the convenience sampling method which is a type of non-probability sampling, a total of 40 subjects will be enrolled. This technique involves selecting a research sample based on convenience \& accessibility, drawing the sample from the part of the population close to hand. In this study, the purpose is to standardize and validate the methods and evaluators' and there is no usage of medicines/test articles/test treatment or test products, specific sample calculation of sample size estimation is not required.
NovoBliss Research Pvt Ltd
Gandhinagar, Gujarat, 382421, India
Dr. Nayan K Patel, MBBS
Medical Director
40 participants (actual enrollment reported by the registry).
First Submitted
February 28, 2023
First Posted
March 10, 2023
Study Start
April 12, 2023
Actual (reported)Pharmacokinetic Study of a Fixed Dose Combination Nefopam Hydrochloride (30 mg) / Paracetamol (500 mg)
Contact the study team to confirm eligibility.
Primary Completion
May 1, 2023
Actual (reported)Study Completion
May 1, 2023
Actual (reported)Last Updated
May 30, 2023
Record last verified: 2023-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: